Reminder: Pharmboy is available to chat with Members, comments are found below each post.
Ahh, summer is almost here, and for many it means vacations, family, lots of sun and vacation proofing your portfolio. While Phil’s post on vacation proofings is a bit dated (maybe we can get him to update it!!), it still can give a premise on what needs to be done when going away for that needed time off and to spend quality time with family.
For now, though, I thought it would be good to review Pharmboy’s 2011 portfolio. There are so many different options on the PSW site with Opt using his 5d MA methods, Income Trader giving picks for iron condors and calendar credit spreads, and All About the Trends following the entry and exit points of trending stocks, there are a plethora of things to choose from for ones investing style. I focus on biotechs and big pharma, as they can be rewarding themselves, as well as cause us lots of angst (thanks DCTH) for our portfolios. Below is the first half of the year and all the picks we have noted in chat, the SWW newsletter, as well as my write ups. Yes there are more, but these are the ones we highlighted.
Table 1. 2011 Picks Thus Far
As one can see, the biotech/pharma portfolio is doing very well. We had several big winners including CEPH, GXDX, OPXA, IMGN and SGEN. We have also had a few losers with PLX and ISTA (although still active, I don’t expect it to win) being hit. There are still many positions and stock picks that are in the portfolio, and I would expect them to be fine by years end (e.g., CELG).
Being the midway point of the year, it would be wise to close out some more winners or see if any adjustments need to be made to ones that are on the loss column.
PDLI will need to be adjusted if the stock has not been called away already. I would roll to the November $6 calls and puts for a net credit of $1.20.
- For IRWD (Jan 14), I would start to reduce the exposure, as they are planning on announcing there successful NDA for Linaclotide. Getting $4 or better is a good ROI for a $1.80 investment.
- BIIB (Feb 6)January 2012 $60 puts can be
…
